Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $ELVN vs $OGN | Chartloom

Compare

$ELVN vs $OGN

Enliven Therapeutics Inc · Organon & Co

ELVN

Enliven Therapeutics Inc

OGN

Organon & Co

Compare $ELVN vs $OGN

Comparing Enliven Therapeutics Inc and Organon & Co

ELVNEnliven Therapeutics Inc

OGNOrganon & Co

ELVNEnliven Therapeutics Inc

Market cap

$2.76B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

154.1%

52W performance

89.7%

FCF yield

-2.4%

OGNOrganon & Co

Market cap

$3.62B

P/E (TTM)

17.82x

Forward P/E (NTM)

3.84x

Forward P/S (NTM)

0.58x

Rev growth (TTM)

-2.5%

YTD performance

90.2%

52W performance

43.4%

FCF yield

12.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ELVN

OGN

Detailed metrics comparison

ELVN

Enliven Therapeutics Inc

OGN

Organon & Co

Market Cap

ELVN$2.76B

OGN$3.62B

Enterprise Value

ELVN$2.62B

OGN$11.04B

Price

ELVN$39.49

OGN$13.77

P/E Ratio

ELVNN/A

OGN17.82x

P/S Ratio

ELVN0.00x

OGN0.59x

EV/Sales

ELVN0.00x

OGN1.80x

EV/EBITDA

ELVN770.73x

OGN6.50x

P/B Ratio

ELVN3.35x

OGN3.61x

P/FCF Ratio

ELVNN/A

OGN8.33x

EV/FCF

ELVN-39.11x

OGN25.43x

PEG Ratio

ELVNN/A

OGNN/A

Forward P/E (NTM)

ELVNN/A

OGN3.84x

Forward P/S (NTM)

ELVNN/A

OGN0.58x

Revenue (TTM)

ELVN$0

OGN$6.13B

Revenue Growth (YoY)

ELVNN/A

OGN-2.5%

Forward Rev Growth

ELVN28.4%

OGN1.6%

Gross Margin (TTM)

ELVN0.0%

OGN52.7%

Operating Margin (TTM)

ELVN0.0%

OGN8.0%

EBITDA Margin (TTM)

ELVN0.0%

OGN27.7%

Net Margin (TTM)

ELVN0.0%

OGN3.4%

FCF Margin (TTM)

ELVNN/A

OGN7.1%

Net Income (TTM)

ELVN$-106M

OGN$209M

FCF (TTM)

ELVN$-67M

OGN$434M

EPS (TTM)

ELVN-$1.60

OGN$0.77

ROE (TTM)

ELVN-1855.0%

OGN23.4%

ROA (TTM)

ELVN-1809.0%

OGN1.6%

ROIC (TTM)

ELVN-1855.0%

OGN2.2%

Cash

ELVN$136M

OGN$1.13B

Debt

ELVN$0

OGN$8.55B

Net Cash/Debt

ELVN$136M

OGN$-7.42B

Current Ratio (TTM)

ELVN64.07x

OGN1.95x

Quick Ratio (TTM)

ELVN63.21x

OGN1.44x

Debt/Equity (TTM)

ELVN0.00x

OGN8.50x

Debt/Assets (TTM)

ELVN0.0%

OGN0.0%

Interest Coverage (TTM)

ELVNN/A

OGNN/A

Net Debt/EBITDA (TTM)

ELVN0.00x

OGN0.00x

Beta

ELVN0.55

OGN1.50

52W Performance

ELVN89.7%

OGN43.4%

YTD Performance

ELVN154.1%

OGN90.2%

% from 52W High

ELVN-36.6%

OGN-0.7%

% from 52W Low

ELVN167.1%

OGN142.0%

Asset Turnover (TTM)

ELVN0.00x

OGN0.47x

FCF Yield (TTM)

ELVN-2.4%

OGN12.0%

Earnings Yield (TTM)

ELVN-3.8%

OGN5.8%

Dividend Yield (TTM)

ELVNN/A

OGN0.5%

Rule of 40

ELVN0.0

OGN4.6

EV/GP/RG

ELVNN/A

OGN2.99

Ticker research

View ELVN research View OGN research

Metric	ELVN Enliven Therapeutics Inc	OGN Organon & Co
Market & Valuation
Market Cap	$2.76B	$3.62B
Enterprise Value	$2.62B	$11.04B
Price	$39.49	$13.77
P/E Ratio	N/A	17.82x
P/S Ratio	0.00x	0.59x
EV/Sales	0.00x	1.80x
EV/EBITDA	770.73x	6.50x
P/B Ratio	3.35x	3.61x
P/FCF Ratio	N/A	8.33x
EV/FCF	-39.11x	25.43x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	3.84x
Forward P/S (NTM)	N/A	0.58x
Revenue & Growth
Revenue (TTM)	$0	$6.13B
Revenue Growth (YoY)	N/A	-2.5%
Forward Rev Growth	28.4%	1.6%
Profitability
Gross Margin (TTM)	0.0%	52.7%
Operating Margin (TTM)	0.0%	8.0%
EBITDA Margin (TTM)	0.0%	27.7%
Net Margin (TTM)	0.0%	3.4%
FCF Margin (TTM)	N/A	7.1%
Net Income (TTM)	$-106M	$209M
FCF (TTM)	$-67M	$434M
EPS (TTM)	-$1.60	$0.77
ROE (TTM)	-1855.0%	23.4%
ROA (TTM)	-1809.0%	1.6%
ROIC (TTM)	-1855.0%	2.2%
Financial Health
Cash	$136M	$1.13B
Debt	$0	$8.55B
Net Cash/Debt	$136M	$-7.42B
Current Ratio (TTM)	64.07x	1.95x
Quick Ratio (TTM)	63.21x	1.44x
Debt/Equity (TTM)	0.00x	8.50x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.55	1.50
52W Performance	89.7%	43.4%
YTD Performance	154.1%	90.2%
% from 52W High	-36.6%	-0.7%
% from 52W Low	167.1%	142.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.47x
FCF Yield (TTM)	-2.4%	12.0%
Earnings Yield (TTM)	-3.8%	5.8%
Dividend Yield (TTM)	N/A	0.5%
Other
Rule of 40	0.0	4.6
EV/GP/RG	N/A	2.99
Ticker research	View ELVN research	View OGN research

Valuation

P/E Ratio

OGN

17.82x

P/S Ratio

ELVN

0.00x

OGN

0.59x

EV/FCF

ELVN

-39.11x

OGN

25.43x

Growth & revenue

Revenue Growth TTM

OGN

-2.5%

Forward Revenue Growth

ELVN

28.4%

OGN

1.6%

Profitability & performance

Gross Margin

OGN

52.7%

ELVN

0.0%

ROE

OGN

23.4%

ELVN

-1855.0%

FCF Yield %

OGN

12.0%

ELVN

-2.4%

52-Week Performance

ELVN

89.7%

OGN

43.4%

Detailed metrics comparison

ELVN

Enliven Therapeutics Inc

OGN

Organon & Co

Market Cap

ELVN$2.76B

OGN$3.62B

Enterprise Value

ELVN$2.62B

OGN$11.04B

Price

ELVN$39.49

OGN$13.77

P/E Ratio

ELVNN/A

OGN17.82x

P/S Ratio

ELVN0.00x

OGN0.59x

EV/Sales

ELVN0.00x

OGN1.80x

EV/EBITDA

ELVN770.73x

OGN6.50x

P/B Ratio

ELVN3.35x

OGN3.61x

P/FCF Ratio

ELVNN/A

OGN8.33x

EV/FCF

ELVN-39.11x

OGN25.43x

PEG Ratio

ELVNN/A

OGNN/A

Forward P/E (NTM)

ELVNN/A

OGN3.84x

Forward P/S (NTM)

ELVNN/A

OGN0.58x

Revenue (TTM)

ELVN$0

OGN$6.13B

Revenue Growth (YoY)

ELVNN/A

OGN-2.5%

Forward Rev Growth

ELVN28.4%

OGN1.6%

Gross Margin (TTM)

ELVN0.0%

OGN52.7%

Operating Margin (TTM)

ELVN0.0%

OGN8.0%

EBITDA Margin (TTM)

ELVN0.0%

OGN27.7%

Net Margin (TTM)

ELVN0.0%

OGN3.4%

FCF Margin (TTM)

ELVNN/A

OGN7.1%

Net Income (TTM)

ELVN$-106M

OGN$209M

FCF (TTM)

ELVN$-67M

OGN$434M

EPS (TTM)

ELVN-$1.60

OGN$0.77

ROE (TTM)

ELVN-1855.0%

OGN23.4%

ROA (TTM)

ELVN-1809.0%

OGN1.6%

ROIC (TTM)

ELVN-1855.0%

OGN2.2%

Cash

ELVN$136M

OGN$1.13B

Debt

ELVN$0

OGN$8.55B

Net Cash/Debt

ELVN$136M

OGN$-7.42B

Current Ratio (TTM)

ELVN64.07x

OGN1.95x

Quick Ratio (TTM)

ELVN63.21x

OGN1.44x

Debt/Equity (TTM)

ELVN0.00x

OGN8.50x

Debt/Assets (TTM)

ELVN0.0%

OGN0.0%

Interest Coverage (TTM)

ELVNN/A

OGNN/A

Net Debt/EBITDA (TTM)

ELVN0.00x

OGN0.00x

Beta

ELVN0.55

OGN1.50

52W Performance

ELVN89.7%

OGN43.4%

YTD Performance

ELVN154.1%

OGN90.2%

% from 52W High

ELVN-36.6%

OGN-0.7%

% from 52W Low

ELVN167.1%

OGN142.0%

Asset Turnover (TTM)

ELVN0.00x

OGN0.47x

FCF Yield (TTM)

ELVN-2.4%

OGN12.0%

Earnings Yield (TTM)

ELVN-3.8%

OGN5.8%

Dividend Yield (TTM)

ELVNN/A

OGN0.5%

Rule of 40

ELVN0.0

OGN4.6

EV/GP/RG

ELVNN/A

OGN2.99

Ticker research

View ELVN research View OGN research

Metric	ELVN Enliven Therapeutics Inc	OGN Organon & Co
Market & Valuation
Market Cap	$2.76B	$3.62B
Enterprise Value	$2.62B	$11.04B
Price	$39.49	$13.77
P/E Ratio	N/A	17.82x
P/S Ratio	0.00x	0.59x
EV/Sales	0.00x	1.80x
EV/EBITDA	770.73x	6.50x
P/B Ratio	3.35x	3.61x
P/FCF Ratio	N/A	8.33x
EV/FCF	-39.11x	25.43x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	3.84x
Forward P/S (NTM)	N/A	0.58x
Revenue & Growth
Revenue (TTM)	$0	$6.13B
Revenue Growth (YoY)	N/A	-2.5%
Forward Rev Growth	28.4%	1.6%
Profitability
Gross Margin (TTM)	0.0%	52.7%
Operating Margin (TTM)	0.0%	8.0%
EBITDA Margin (TTM)	0.0%	27.7%
Net Margin (TTM)	0.0%	3.4%
FCF Margin (TTM)	N/A	7.1%
Net Income (TTM)	$-106M	$209M
FCF (TTM)	$-67M	$434M
EPS (TTM)	-$1.60	$0.77
ROE (TTM)	-1855.0%	23.4%
ROA (TTM)	-1809.0%	1.6%
ROIC (TTM)	-1855.0%	2.2%
Financial Health
Cash	$136M	$1.13B
Debt	$0	$8.55B
Net Cash/Debt	$136M	$-7.42B
Current Ratio (TTM)	64.07x	1.95x
Quick Ratio (TTM)	63.21x	1.44x
Debt/Equity (TTM)	0.00x	8.50x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.55	1.50
52W Performance	89.7%	43.4%
YTD Performance	154.1%	90.2%
% from 52W High	-36.6%	-0.7%
% from 52W Low	167.1%	142.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.47x
FCF Yield (TTM)	-2.4%	12.0%
Earnings Yield (TTM)	-3.8%	5.8%
Dividend Yield (TTM)	N/A	0.5%
Other
Rule of 40	0.0	4.6
EV/GP/RG	N/A	2.99
Ticker research	View ELVN research	View OGN research